Mir-125 in Normal and Malignant Hematopoiesis

Total Page:16

File Type:pdf, Size:1020Kb

Mir-125 in Normal and Malignant Hematopoiesis Leukemia (2012) 26, 2011–2018 & 2012 Macmillan Publishers Limited All rights reserved 0887-6924/12 www.nature.com/leu SPOTLIGHT REVIEW MiR-125 in normal and malignant hematopoiesis L Shaham1,2, V Binder3,4,NGefen1,5, A Borkhardt3 and S Izraeli1,5 MiR-125 is a highly conserved microRNA throughout many different species from nematode to humans. In humans, there are three homologs (hsa-miR-125b-1, hsa-miR-125b-2 and hsa-miR-125a). Here we review a recent research on the role of miR-125 in normal and malignant hematopoietic cells. Its high expression in hematopoietic stem cells (HSCs) enhances self-renewal and survival. Its expression in specific subtypes of myeloid and lymphoid leukemias provides resistance to apoptosis and blocks further differentiation. A direct oncogenic role in the hematopoietic system has recently been demonstrated by several mouse models. Targets of miR-125b include key proteins regulating apoptosis, innate immunity, inflammation and hematopoietic differentiation. Leukemia (2012) 26, 2011–2018; doi:10.1038/leu.2012.90 Keywords: microRNA; hematopoiesis; hematological malignancies; acute myeloid leukemia; acute lymphoblastic leukemia MicroRNAs (miRNAs) are 21–23-nucleotide non-coding RNAs that nucleotides with the seed region of miR-125b (ebv-miR-BART21-5p, have crucial roles in fundamental biological processes by ebv-miR-BART8 and rlcv-miR-rL1-25). In humans, as in most of the regulating the levels of multiple proteins. They are transcribed genomes, there are two paralogs (hsa-miR-125b-1 on chromosome as primary miRNAs and processed in the nucleus by the RNase III 11 and hsa-miR-125b-2 on chromosome 21), coding for the same endonuclease DROSHA to liberate 70-nucleotide stem loops, the mature sequence. There is no obvious correlation between precursor miRNA. The precursor miRNAs are then exported from the number of paralogs and the complexity of the genome, as the nucleus to the cytoplasm by Exportin 5/RanGTP, where further the genome of the zebrafish (Danio rerio) contains three paralogs cleavage by the second RNase III enzyme DICER releases the of miR-125b, whereas there is only one copy in chimpanzees (Pan mature miRNAs.1–3 MiRNAs bind mainly to the 30untranslated paniscus), pufferfish (Tetraodon nigroviridis) or worms (Schistosoma region of mRNAs by direct base-pairing to the 50miRNA japonicum, Schmidtea mediterranea). seed region, resulting either in repression of gene translation1 In addition to paralogs that code for the same mature or induction of mRNA degradation.2 Recent data reveals, sequence, there are homologs that code for different mature however, that miRNA regulation entails a far more complex sequences, which contain the same seed region and therefore posttranscriptional control than initially anticipated.3 might have similar functions. In the human genome, the homolog Many miRNAs are genomically organized as clusters and are co- miR-125a is encoded on chromosome 19. In some other species transcribed from a single promoter as a single polycistronic (Danio rerio), there are three homologs encoded on different transcript, although inconsistent expression of members can be chromosomes (miR-125a, -125b and -125c), all sharing the same detected in some miRNA clusters.4,5 seed region (Figure 1a). Interestingly, miR-351, which is encoded Here, we review the role of miR-125 in normal and malignant only in the mouse and rat genome, has the same seed region as hematopoiesis. MiR-125, a highly conserved miRNA transcribed miR-125b. from three different clusters, has recently emerged as a key In humans, miR-125b-2 is organized in a cluster with miR-99a regulator of HSCs. It has been shown to be dysregulated in and let-7c. Hsa-miR-125b-2 is encoded B50 kb downstream of multiple malignancies and to affect cell survival, differentiation hsa-miR-99a and hsa-let-7c, which are located about 650 bp from SPOTLIGHT and proliferation through the suppression of multiple targets. each other. Although the distance of 50 kb is greater than the These fascinating recent discoveries raise many questions regard- standard distance for a cluster, analysis of various genomes shows ing its regulation, interactions with additional co-transcribed that this region is highly conserved in its organization, and miRNAs and mechanisms of activity. therefore this region is considered to be a cluster. A second cluster (on chromosome 11 in humans) contains the paralog miR-125b-1 with let-7a-2 and miR-100, which both differ in only one GENOMIC ORGANIZATION OF THE MIR-125B CLUSTER nucleotide outside of the seed region of their family members, MiR-125b is highly conserved among mammals, vertebrates let-7c and miR-99a, respectively. The genomic organization of and nematodes. Although the nomenclature sometimes differ this second cluster is similar to that of the first. A third cluster (for example cel-lin-4 in Caenorhabditis elegans), the seed region is (on chromosome 19 in humans) contains miR-99b, let-7e and the same throughout all species containing miR-125b (Figure 1a). miR-125a. Here, all three miRNAs are encoded close to each In viral genomes, there is a maximum concordance of only six other (o1 kb). 1Department of Pediatric Hemato-Oncology, Functional Genomics and Childhood Leukemia Research, Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan, Israel; 2The Mina & Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, Israel; 3Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine University, Du¨sseldorf, Germany; 4Stem Cell Program and Division of Hematology/Oncology, Children’s Hospital, Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA and 5Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Correspondence: Professor S Izraeli, Department of Pediatric Hemato-Oncology, Functional Genomics and Childhood Leukemia Research, Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel. E-mail [email protected] The study is partial fulfillment of the requirements for completing a PhD degree (Lital Shaham) for Bar-Ilan University, Ramat Gan, Israel. Received 27 April 2011; revised 12 March 2012; accepted 13 March 2012; accepted article preview online 29 March 2012; advance online publication, 24 April 2012 Mir 125 in hematopoiesis and leukemia L Shaham et al 2012 Seed region Host gene‚ MiR-100-let-7a-2 cluster host gene‘ 1 2 [-] Chr 11 Hsa-miR-100 Hsa-let-7a-2 Hsa-miR-125b-1 50 kb 6 kb 47 kb Host gene‚ LINC00478‘ 3 4 [+] Chr 21 SPOTLIGHT Hsa-miR-99a Hsa-let-7c Hsa-miR-125b-2 470 kb <1 kb 50 kb 5 [+] Chr 19 Hsa-miR-99b Hsa1-let-7e Hsa-miR-125a <1 kb <1 kb Figure 1. (a) The seed region of homologs and orthologs of miR-125 is highly conserved throughout different species. (b) Genomic organization of the miR-cluster containing miR-125, shown together with their host genes and potential promoter regions. 1: A putative promoter predicted by Long et al.,7 Wang et al.,9 Ozsolak et al.8 and Corcoran et al.6 2: A putative promoter predicted by Long et al.,7 Wang et al.,9 and Corcoran et al. 6 3: A putative promoter predicted by Long et al.,7 Wang et al.,9 Ozsolak et al.,8 Corcoran et al.,6 and Montey et al.11 4: A putative promoter predicted by Corcoran et al.,6 and Ozsolak et al.8 5: A putative promoter predicted by Long et al.,7 Wang et al.,9 Ozsolak et al.,8 and Corcoran et al.6 Dashed lines indicate structures that were annotated only in a single study. This composition suggests that the cluster containing miR-125a the miR-125b clusters. Whereas most of the studies agree on probably has only one promoter and is transcribed as one hsa-miR-99a, hsa-let-7c and hsa-miR-125b-2 being intragenic transcript, whereas the cluster containing miR-125b may (host gene LINC00478, chr 21: 17.442.842–17.982.094; contain an alternative promoter, making it possible to transcribe NC_000021.8, NCBI build 37.2) and hsa-miR-100, hsa-let-7a-2, miR-125b solely (Figure 1b).6–9 This hypothesis is supported by hsa-miR-125b-1, hsa-miR-99b, hsa-let-7e and hsa-miR-125a being recent research predicting miRNA promoters by combining intergenic, Corcoran et al.6 claim that hsa-miR-100 and hsa-let-7a-2 bioinformatic analysis of nearby upstream DNA regulatory are also intragenic (host gene, non-protein coding, chr 11: elements (transcription start sites (TSS), conserved transcription 121.959.811–122.073.770; NC_000011.9, AK091713). Several factor-binding sites, TATA boxes, A/B boxes) and epigenetic independent putative promoters have been described modifications (CpG islands, histone modifications, nucleosome (Figure 1b). One that drives co-expression of hsa-miR-100 and positioning patterns) with chromatin immunopreciptiation hsa-let-7a-2 independent of their potential host gene,6–9 one that screens or reporter assays.6–11 drives co-expression of hsa-miR-99a and hsa-let-7c independent of It seems that about half of the miRNAs located in introns their host gene,6–9,11 and another that drives co-expression of protein-coding genes (B60%) contain putative promoters of hsa-miR-99b, hsa-let-7c and hsa-miR-125a.6–9 Hsa-miR-125b- regulating transcription independent of their host gene.7 This is 1(refs 6,7,9) and hsa-miR-125b-2(refs 6,8) are predicted to be expressed also supported by the observed discrepancy in expression of from an independent promoter. several miRNAs and their host genes.12,13 Ozsolak et al.8 showed In summary, all three human homologs of miR-125 are involved that intronic miRNAs having independent transcription initiation in a cluster containing members of the miR-99 and let-7 family.
Recommended publications
  • Not Dicer but Argonaute Is Required for a Microrna Production
    Cell Research (2010) 20:735-737. npg © 2010 IBCB, SIBS, CAS All rights reserved 1001-0602/10 $ 32.00 RESEARCH HIGHLIGHT www.nature.com/cr A new twist in the microRNA pathway: Not Dicer but Argonaute is required for a microRNA production Gabriel D Bossé1, Martin J Simard1 1Laval University Cancer Research Centre, Hôtel-Dieu de Québec (CHUQ), Quebec City, Québec G1R 2J6, Canada Cell Research (2010) 20:735-737. doi:10.1038/cr.2010.83; published online 15 June 2010 Found in all metazoans, microRNAs A Canonical pathway B Ago2-dependent pathway or miRNAs are small non-coding RNA Nucleus Cytoplasm Nucleus Cytoplasm of ~22 nucleotides in length that com- Exp.5 Exp.5 pletely reshaped our understanding of gene regulation. This new class of gene pre-miR-451 regulator is mostly transcribed by the pre-miRNA RNA polymerase II producing a long stem-loop structure, called primary- or Ago2 pri-miRNA, that will first be processed Ago2 Dicer in the cell nucleus by a multiprotein TRBP complex called microprocessor to gen- erate a shorter RNA structure called Ago2 RISC precursor- or pre-miRNA. The precisely Ago2 RISC processed pre-miRNA will next be ex- ported into the cytoplasm by Exportin 5 and loaded onto another processing machine containing the ribonuclease III enzyme Dicer, an Argonaute protein Ago2 Ago2 and other accessory cellular factors mRNA mRNA (Figure 1A; [1]). Dicer will mediate the Translation inhibition Translation inhibition cleavage of the pre-miRNA to form the mature miRNA that will then be bound Figure 1 (A) Canonical microRNA biogenesis. In mammals, the pre-miRNA is by the Argonaute protein to form, most loaded onto a multiprotein complex consisting minimally of Dicer, Tar RNA Bind- likely with other cellular factors, the ef- ing Protein (TRBP) and Ago2.
    [Show full text]
  • EIF2C2 Monoclonal Antibody (M01), Clone 2E12-1C9
    EIF2C2 monoclonal antibody (M01), clone 2E12-1C9 Catalog # : H00027161-M01 規格 : [ 100 ug ] List All Specification Application Image Product Mouse monoclonal antibody raised against a full length recombinant Western Blot (Cell lysate) Description: EIF2C2. Immunogen: EIF2C2 (AAH07633.1, 483 a.a. ~ 859 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Sequence: MPIQGQPCFCKYAQGADSVEPMFRHLKNTYAGLQLVVVILPGKTPVYAE VKRVGDTVLGMATQCVQMKNVQRTTPQTLSNLCLKINVKLGGVNNILLP enlarge QGRPPVFQQPVIFLGADVTHPPAGDGKKPSIAAVVGSMDAHPNRYCATV Western Blot (Transfected RVQQHRQEIIQDLAAMVRELLIQFYKSTRFKPTRIIFYRDGVSEGQFQQV lysate) LHHELLAIREACIKLEKDYQPGITFIVVQKRHHTRLFCTDKNERVGKSGNIP AGTTVDTKITHPTEFDFYLCSHAGIQGTSRPSHYHVLWDDNRFSSDELQI LTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLVDKEHDSAEGSHTS GQSNGRDHQALAKAVQVHQDTLRTMYFA Host: Mouse enlarge Reactivity: Human Western Blot (Recombinant Isotype: IgG1 Kappa protein) Quality Control Antibody Reactive Against Recombinant Protein. Immunofluorescence Testing: enlarge Immunohistochemistry (Formalin/PFA-fixed paraffin- embedded sections) Western Blot detection against Immunogen (68.03 KDa) . Storage Buffer: In 1x PBS, pH 7.4 enlarge Storage Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. Instruction: Sandwich ELISA (Recombinant protein) MSDS: Download Interspecies Mouse (100); Rat (99) Antigen Sequence: enlarge Datasheet: Download ELISA Publication Reference RNAi Knockdown (Antibody validated) 1. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance
    [Show full text]
  • EIF2C2 Monoclonal Antibody (M01), Clone 2E12-1C9
    Produktinformation Diagnostik & molekulare Diagnostik Laborgeräte & Service Zellkultur & Verbrauchsmaterial Forschungsprodukte & Biochemikalien Weitere Information auf den folgenden Seiten! See the following pages for more information! Lieferung & Zahlungsart Lieferung: frei Haus Bestellung auf Rechnung SZABO-SCANDIC Lieferung: € 10,- HandelsgmbH & Co KG Erstbestellung Vorauskassa Quellenstraße 110, A-1100 Wien T. +43(0)1 489 3961-0 Zuschläge F. +43(0)1 489 3961-7 [email protected] • Mindermengenzuschlag www.szabo-scandic.com • Trockeneiszuschlag • Gefahrgutzuschlag linkedin.com/company/szaboscandic • Expressversand facebook.com/szaboscandic EIF2C2 monoclonal antibody (M01), clone 2E12-1C9 Catalog # : H00027161-M01 規格 : [ 100 ug ] List All Specification Application Image Product Mouse monoclonal antibody raised against a full length recombinant Western Blot (Cell lysate) Description: EIF2C2. Immunogen: EIF2C2 (AAH07633.1, 1 a.a. ~ 377 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Sequence: MPIQGQPCFCKYAQGADSVEPMFRHLKNTYAGLQLVVVILPGKTPVYAE VKRVGDTVLGMATQCVQMKNVQRTTPQTLSNLCLKINVKLGGVNNILLP enlarge QGRPPVFQQPVIFLGADVTHPPAGDGKKPSIAAVVGSMDAHPNRYCATV Western Blot (Transfected RVQQHRQEIIQDLAAMVRELLIQFYKSTRFKPTRIIFYRDGVSEGQFQQV lysate) LHHELLAIREACIKLEKDYQPGITFIVVQKRHHTRLFCTDKNERVGKSGNIP AGTTVDTKITHPTEFDFYLCSHAGIQGTSRPSHYHVLWDDNRFSSDELQI LTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLVDKEHDSAEGSHTS GQSNGRDHQALAKAVQVHQDTLRTMYFA Host: Mouse enlarge Reactivity: Human Western Blot (Recombinant Isotype: IgG1 Kappa
    [Show full text]
  • Identification of Sequence Variants
    Wang et al. BMC Medical Genomics (2019) 12:28 https://doi.org/10.1186/s12920-019-0475-x RESEARCH ARTICLE Open Access Identification of sequence variants associated with severe microtia-astresia by targeted sequencing Pu Wang1, Yibei Wang1, Xinmiao Fan1, Yaping Liu2, Yue Fan1, Tao Liu3, Chongjian Chen3, Shuyang Zhang4*† and Xiaowei Chen1*† Abstract Background: Microtia-atresia is characterized by abnormalities of the auricle (microtia) and aplasia or hypoplasia of the external auditory canal, often associated with middle ear abnormalities. To date, no causal genetic mutations or genes have been identified in microtia-atresia patients. Methods: We designed a panel of 131 genes associated with external/middle or inner ear deformity. Targeted genomic capturing combined with next-generation sequencing (NGS) was utilized to screen for mutations in 40 severe microtia-atresia patients. Mutations detected by NGS were filtered and validated. And then mutations were divided into three categories—rare or novel variants, low-frequency variants and common variants—based on their frequency in the public database. The rare or novel mutations were prioritized by pathogenicity analysis. For the low-frequency variants and common variants, we used association studies to explore risk factors of severe microtia-atresia. Results: Sixty-five rare heterozygous mutations of 42 genes were identified in 27 (67.5%) severe microtia-atresia patients. Association studies to determine genes that were potentially pathogenic found that PLEC, USH2A, FREM2, DCHS1, GLI3, POMT1 and GBA genes were significantly associated with severe microtia-atresia. Of these, DCHS1 was strongly suggested to cause severe microtia-atresia as it was identified by both low-frequency and common variants association studies.
    [Show full text]
  • Relative Contribution of Sequence and Structure Features to the Mrna Binding of Argonaute/ EIF2C–Mirna Complexes and the Degradation of Mirna Targets
    Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Letter Relative contribution of sequence and structure features to the mRNA binding of Argonaute/ EIF2C–miRNA complexes and the degradation of miRNA targets Jean Hausser,1,3 Markus Landthaler,2,3,4 Lukasz Jaskiewicz,1 Dimos Gaidatzis,1,5 and Mihaela Zavolan1,6 1Biozentrum, University of Basel and Swiss Institute of Bioinformatics, CH-4056 Basel, Switzerland; 2Howard Hughes Medical Institute, Laboratory for RNA Biology, The Rockefeller University, New York, New York 10021, USA How miRNAs recognize their target sites is a puzzle that many experimental and computational studies aimed to solve. Several features, such as perfect pairing of the miRNA seed, additional pairing in the 39 region of the miRNA, relative position in the 39 UTR, and the A/Ucontent of the environment of the putative site, have been found to be relevant. Here we have used a large number of previously published data sets to assess the power that various sequence and structure features have in distinguishing between putative sites that do and those that do not appear to be functional. We found that although different data sets give widely different answers when it comes to ranking the relative importance of these features, the sites inferred from most transcriptomics experiments, as well as from comparative genomics, appear similar at this level. This suggests that miRNA target sites have been selected in evolution on their ability to trigger mRNA degradation. To understand at what step in the miRNA-induced response individual features play a role, we transfected human HEK293 cells with miRNAs and analyzed the association of Argonaute/EIF2C–miRNA complexes with target mRNAs and the degradation of these messages.
    [Show full text]
  • Molds Aboard the International Space Station
    Mold Species in Dust from the International Space Station Identified and Quantified by Mold Specific Quantitative PCR Stephen J. Vesper a*, Wing Wongb C. Mike Kuoc, Duane L. Piersond a National Exposure Research Laboratory (NERL), United States (US) Environmental Protection Agency, Cincinnati, OH; b Enterprise Advisory Services Inc., Houston, TX c WYLE Laboratories Inc., Houston, TX d Johnson Space Center, National Aeronautics and Space Administration, Houston, TX *Corresponding Author: Stephen Vesper, US EPA, 26 West M.L. King Ave., M.L. 314, Cincinnati, Ohio 45268. Phone: 513-569-7367; email: [email protected] Abstract Dust was collected over a period of several weeks in 2007 from HEPA filters in the U.S. Laboratory Module of the International Space Station (ISS). The dust was returned on the Space Shuttle Atlantis, mixed, sieved, and the DNA was extracted. Using a DNA- based method called mold specific quantitative PCR (MSQPCR), 39 molds were measured in the dust. Potential opportunistic pathogens Aspergillus flavus and A. niger and potential moderate toxin producers Penicillium chrysogenum and P. brevicompactum were noteworthy. No cells of the potential opportunistic pathogens A. fumigatus, A. terreus, Fusarium solani or Candida albicans were detected. Keywords: International Space Station, mold specific quantitative PCR, Aspergillus 1 1. Introduction Since human space exploration began, microbes have traveled with us and are ubiquitous throughout the spacecraft. Previous studies have demonstrated that bacteria, including potential pathogens, were commonly isolated in the air, water, and on surfaces aboard the Mir Space Station [12] and the International Space Station (ISS) [1,6]. Biofilms were found in the water distribution lines on the Space Shuttle Discovery [5].
    [Show full text]
  • Dysregulated RNA-Induced Silencing Complex (RISC) Assembly Within CNS Corresponds with Abnormal Mirna Expression During Autoimmune Demyelination
    The Journal of Neuroscience, May 13, 2015 • 35(19):7521–7537 • 7521 Neurobiology of Disease Dysregulated RNA-Induced Silencing Complex (RISC) Assembly within CNS Corresponds with Abnormal miRNA Expression during Autoimmune Demyelination Przemysław Lewkowicz, Hanna Cwiklin´ska, Marcin P. Mycko, Maria Cichalewska, Małgorzata Domowicz, Natalia Lewkowicz, Anna Jurewicz, and Krzysztof W. Selmaj Department of Neurology, Laboratory of Neuroimmunology, Medical University of Lodz, 92-213 Lodz, Poland MicroRNAs (miRNAs) associate with Argonaute (Ago), GW182, and FXR1 proteins to form RNA-induced silencing complexes (RISCs). RISCs represent a critical checkpoint in the regulation and bioavailability of miRNAs. Recent studies have revealed dysregulation of miRNAs in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE); however, the function of RISCs in EAE and MS is largely unknown. Here, we examined the expression of Ago, GW182, and FXR1 in CNS tissue, oligodendrocytes (OLs), brain-infiltrating T lymphocytes, and CD3 ϩsplenocytes (SCs) of EAE mic, and found that global RISC protein levels were signifi- cantly dysregulated. Specifically, Ago2 and FXR1 levels were decreased in OLs and brain-infiltrating T cells in EAE mice. Accordingly, assembly of Ago2/GW182/FXR1 complexes in EAE brain tissues was disrupted, as confirmed by immunoprecipitation experiments. In parallel with alterations in RISC complex content in OLs, we found downregulation of miRNAs essential for differentiation and survival of OLs and myelin synthesis. In brain-infiltrating T lymphocytes, aberrant RISC formation contributed to miRNA-dependent proinflam- matory helper T-cell polarization. In CD3 ϩ SCs, we found increased expression of both Ago2 and FXR1 in EAE compared with nonim- munized mice.
    [Show full text]
  • NIH Public Access Author Manuscript Epigenetics
    NIH Public Access Author Manuscript Epigenetics. Author manuscript; available in PMC 2009 June 23. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Epigenetics. 2007 ; 2(2): 126±134. Epigenetics and Neural Developmental Disorders: Washington DC, September 18 and 19, 2006 Xinyu Zhao1,*, ChangHui Pak2, Richard D. Smrt1, and Peng Jin2,* 1 Department of Neuroscience; University of New Mexico School of Medicine; Albuquerque, New Mexico USA 2 Department of Human Genetics; Emory University School of Medicine; Atlanta, Georgia USA Abstract Neural developmental disorders, such as autism, Rett Syndrome, Fragile X syndrome, and Angelman syndrome manifest during early postnatal neural development. Although the genes responsible for some of these disorders have been identified, how the mutations of these genes affect neural development is currently unclear. Emerging evidence suggest that these disorders share common underlying defects in neuronal morphology, synaptic connectivity and brain plasticity. In particular, alterations in dendritic branching and spine morphology play a central role in the pathophysiology of most mental retardation disorders, suggesting that common pathways regulating neuronal function may be affected. Epigenetic modulations, mediated by DNA methylation, RNA-associated silencing, and histone modification, can serve as an intermediate process that imprints dynamic environmental experiences on the “fixed” genome, resulting in stable alterations in phenotypes. Disturbance in epigenetic regulations can lead to inappropriate expression or silencing of genes, causing an array of multi-system disorders and neoplasias. Rett syndrome, the most common form of mental retardation in young girls, is due to l mutation of MECP2, encoding a methylated DNA binding protein that translates DNA methylation into gene repression.
    [Show full text]
  • T Lymphocytes Mrna, and Protein Expression in Activated Networks
    MicroRNA Regulation of Molecular Networks Mapped by Global MicroRNA, mRNA, and Protein Expression in Activated T Lymphocytes This information is current as of September 23, 2021. Yevgeniy A. Grigoryev, Sunil M. Kurian, Traver Hart, Aleksey A. Nakorchevsky, Caifu Chen, Daniel Campbell, Steven R. Head, John R. Yates III and Daniel R. Salomon J Immunol 2011; 187:2233-2243; Prepublished online 25 July 2011; Downloaded from doi: 10.4049/jimmunol.1101233 http://www.jimmunol.org/content/187/5/2233 http://www.jimmunol.org/ Supplementary http://www.jimmunol.org/content/suppl/2011/07/25/jimmunol.110123 Material 3.DC1 References This article cites 83 articles, 31 of which you can access for free at: http://www.jimmunol.org/content/187/5/2233.full#ref-list-1 Why The JI? Submit online. by guest on September 23, 2021 • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2011 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology MicroRNA Regulation of Molecular Networks Mapped by Global MicroRNA, mRNA, and Protein Expression in Activated T Lymphocytes Yevgeniy A.
    [Show full text]
  • Specific Aim # 2A to Determine If Mir-122 Down-Regulates OCLN In
    NOVEL ROLES OF MICRORNAS IN HEPATITIS C by Hossein Sendi A dissertation submitted to the faculty of The University of North Carolina at Charlotte in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biology Charlotte 2013 Approved by: ______________________________ Dr. Mark G. Clemens ______________________________ Dr. Herbert L. Bonkovsky ______________________________ Dr. Laura W. Schrum _____________________________ Dr. Valery Grdzelishvili ____________________________ Dr. Kent E. Curran ii ©2013 Hossein Sendi ALL RIGHTS RESERVED iii ABSTRACT HOSSEIN SENDI. Novel roles of microRNAs in hepatitis C. (Under the direction of MARK CLEMENS and HERBERT BONKOVSKY) Approximately, 170 million people are infected by hepatitis C virus (HCV) worldwide, and of these, nearly 85% will develop chronic hepatitis C (CHC). Despite finding new anti-viral treatment that increase response rate from 45 % to 65-70 %, investigations continue to find more effective treatments for hepatitis C because of side effects and limitations of current treatment. It is known that miR-122 enhances HCV replication by binding to two closely spaced target sites in the 5’-UTR of the viral genome, which leads to an increase in abundance of HCV RNA. We found that miR-122 down- regulates Occludin (OCLN), one of the key HCV receptors, by directly targeting 3’-UTR of OCLN mRNA. We also found that interaction of miR-122 with 3’-UTR of OCLN mRNA eventually results in a decrease in HCV entry. In accordance with our in vitro study, we found an inverse correlation between pre-treatment levels of miR-122 and HCV RNA levels in patients with CHC. This is a new finding of our study which is consonant with our hypothesis that miR-122 may play an antiviral role in uninfected hepatocytes and early stages of HCV infection.
    [Show full text]
  • A Catalogue of Stress Granules' Components
    Catarina Rodrigues Nunes A Catalogue of Stress Granules’ Components: Implications for Neurodegeneration UNIVERSIDADE DO ALGARVE Departamento de Ciências Biomédicas e Medicina 2019 Catarina Rodrigues Nunes A Catalogue of Stress Granules’ Components: Implications for Neurodegeneration Master in Oncobiology – Molecular Mechanisms of Cancer This work was done under the supervision of: Clévio Nóbrega, Ph.D UNIVERSIDADE DO ALGARVE Departamento de Ciências Biomédicas e Medicina 2019 i ii A catalogue of Stress Granules’ Components: Implications for neurodegeneration Declaração de autoria de trabalho Declaro ser a autora deste trabalho, que é original e inédito. Autores e trabalhos consultados estão devidamente citados no texto e constam na listagem de referências incluída. I declare that I am the author of this work, that is original and unpublished. Authors and works consulted are properly cited in the text and included in the list of references. _______________________________ (Catarina Nunes) iii Copyright © 2019 Catarina Nunes A Universidade do Algarve reserva para si o direito, em conformidade com o disposto no Código do Direito de Autor e dos Direitos Conexos, de arquivar, reproduzir e publicar a obra, independentemente do meio utilizado, bem como de a divulgar através de repositórios científicos e de admitir a sua cópia e distribuição para fins meramente educacionais ou de investigação e não comerciais, conquanto seja dado o devido crédito ao autor e editor respetivos. iv Part of the results of this thesis were published in Nunes,C.; Mestre,I.; Marcelo,A. et al. MSGP: the first database of the protein components of the mammalian stress granules. Database (2019) Vol. 2019. (In annex A). v vi ACKNOWLEDGEMENTS A realização desta tese marca o final de uma etapa académica muito especial e que jamais irei esquecer.
    [Show full text]
  • Apollo-Soyuz Test Project
    --.I m ...ir,,.= The document_-contains materials on the Soyuz-Apollo test and consists of two parts, prepared by the USSR and USA sides res- pectively. Both parts outline the purposes and program of the mission, the spacecraft design, the flight plan and information on Joint and unilateral scientific experiments. Brief biographies of the cosmonauts and astronauts, the Joint mission crew members_ are also presented. The document covers technical support activities providing mission control and gives information about the ASTP Soviet and American leaders. As the USSR and USA parts of the document have been prepared independently, there might be duplication in the sections dealing with the Joint activities. The document is intended for press representatives and various mass information means. CONTENTS Page I.0 INTRODUCTION ....................................... 10 1.1 Background ......................................... I0 1,2 Apollo-Soyuz joint test project objectives .......... 13 2.0 COMPATIBILITY PROBLEMS ................... ......... • 15 2.1 Spacecraft compatibility conditions and principal solutions accepted for Apollo-Ssyuz Test Mission .... 15 2.2 Compatibility of ground flight control personnel ... 18 2_3 Methodological compatibility ....................... 20 3.0 SOYUZ SPACECRAFT ................................... 22 3.1 PurPose. Brief data on Soyuz spacecraft flights .... 22 3.2 Soyuz spacecraft description ....................... 25 3.2.1 General description of the Soyuz spacecraft.. 25 Main characteristics ........................
    [Show full text]